Blood cancers are malignant tumors of the hematological system, including acute leukemia, lymphoma, and multiple myeloma. The survival of patients cannot be generalized, but is mainly related to the type and stage of disease and whether standardized treatment is adopted.
Blood cancer is a common malignant tumor in hematology, the specific cause of which is not yet clear, and can be divided into acute leukemia, lymphoma, multiple myeloma and other diseases. For early detected blood cancers, patients need to undergo bone marrow transplantation, chemotherapy and biological therapy in time, and some patients can achieve clinical cure and then long-term survival. For middle and late stage blood cancers, the survival time varies from person to person, which may be as short as a few months or 1-2 years, or as long as 5-10 years, depending on the patient’s physical condition.
With the progress of medical science, there are more and more treatment methods and drugs for blood cancer, and patients are advised to actively cooperate with the treatment, which can effectively prolong the survival period.